MRC Technology has licensed an antibody to Newsummit Biopharma for development of a novel therapeutic for treatment of Hepatitis C virus (HCV) infection.
MRC Technology is committed to ensuring that promising medical research is protected and progressed to benefit patients.…
MRC Technology has appointed Steve Visscher CBE to its board of trustees.
Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets that could lead to new immunotherapy treatments.
Edinburgh, Scotland, 17 January 2017: MRC Technology, an independent medical research charity, has announced the relocation of…
MRC Technology has announced the relocation of its Centre for Diagnostics Development (CDD) to Nine, Edinburgh BioQuarter. The move forms part of the charity’s investment of over £7million over the next five years to further its work accelerating diagnostic research into the clinic.